Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models.
Lim YS, Yoo SM, Patil V, Kim HW, Kim HH, Suh B, Park JY, Jeong NR, Park CH, Ryu JH, Lee BH, Kim P, Lee SH.
Lim YS, et al. Among authors: lee sh, lee bh.
Blood Adv. 2023 Jan 10;7(1):92-105. doi: 10.1182/bloodadvances.2022008121.
Blood Adv. 2023.
PMID: 36269842
Free PMC article.